Assembly Biosciences announces $15.75 million registered direct offering
Assembly Biosciences announced it entered into an agreement with institutional investors for the sale of 1,959,000 shares of its common stock at the price of $8.04 per share, resulting in $15.75 million in gross proceeds. The financing includes both existing and new investors. October 01, 2014